{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:52:23Z","timestamp":1782766343577,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11033-021-06499-3","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T09:02:35Z","timestamp":1624093355000},"page":"5057-5062","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1\/BRCA2"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6050-816X","authenticated-orcid":false,"given":"Ibrahim","family":"Sahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6087-5947","authenticated-orcid":false,"given":"Hanife","family":"Saat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,19]]},"reference":[{"key":"6499_CR1","unstructured":"Howlader N, Noone A, Krapcho M, et al (2015) SEER Cancer Statistics Review. National Cancer Institute 1975\u20132012. http:\/\/seer.cancer.gov\/csr\/1975_2012\/, based on November 2014 SEER data submission, posted to the SEER web site."},{"key":"6499_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ygyno.2016.03.007","volume":"141","author":"LM Randall","year":"2016","unstructured":"Randall LM, Pothuri B (2016) The genetic prediction of risk for gynecologic cancers. Gynecol Oncol 141:10\u201316. https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.007","journal-title":"Gynecol Oncol"},{"key":"6499_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamasurg.2017.0552","volume":"152","author":"OM Valencia","year":"2017","unstructured":"Valencia OM, Samuel SE, Viscusi RK et al (2017) The role of genetic testing in patients with breast cancer a review. JAMA Surg 152:589\u2013594","journal-title":"JAMA Surg"},{"key":"6499_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1934-1","author":"BK Eccles","year":"2015","unstructured":"Eccles BK, Copson E, Maishman T et al (2015) Understanding of BRCA VUS genetic results by breast cancer specialists. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-015-1934-1","journal-title":"BMC Cancer"},{"key":"6499_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D et al (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105:812\u2013822. https:\/\/doi.org\/10.1093\/jnci\/djt095","journal-title":"J Natl Cancer Inst"},{"key":"6499_CR6","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1002\/cncr.27556","volume":"118","author":"T Judkins","year":"2012","unstructured":"Judkins T, Rosenthal E, Arnell C et al (2012) Clinical significance of large rearrangements in BRCA1 and BRCA2. Cancer 118:5210\u20135216. https:\/\/doi.org\/10.1002\/cncr.27556","journal-title":"Cancer"},{"key":"6499_CR7","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358\u20131365. https:\/\/doi.org\/10.1093\/jnci\/94.18.1358","journal-title":"J Natl Cancer Inst"},{"key":"6499_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","volume":"125","author":"MD Sluiter","year":"2011","unstructured":"Sluiter MD, Van Rensburg EJ (2011) Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat 125:325\u2013349. https:\/\/doi.org\/10.1007\/s10549-010-0817-z","journal-title":"Breast Cancer Res Treat"},{"key":"6499_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cancergencyto.2005.07.005","volume":"168","author":"S Preisler-Adams","year":"2006","unstructured":"Preisler-Adams S, Sch\u00f6nbuchner I, Fiebig B et al (2006) Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin. Cancer Genet Cytogenet 168:44\u201349. https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.07.005","journal-title":"Cancer Genet Cytogenet"},{"key":"6499_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/humu.10133","volume":"20","author":"JAL Armour","year":"2002","unstructured":"Armour JAL, Barton DE, Cockburn DJ, Taylor GR (2002) The detection of large deletions or duplications in genomic DNA. Hum Mutat 20:325\u2013337","journal-title":"Hum Mutat"},{"key":"6499_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-018-0046-7","author":"AE Toland","year":"2018","unstructured":"Toland AE, Forman A, Couch FJ et al (2018) Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices. NPJ Genomic Med. https:\/\/doi.org\/10.1038\/s41525-018-0046-7","journal-title":"NPJ Genomic Med"},{"key":"6499_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41436-019-0655-2","volume":"22","author":"T Brandt","year":"2020","unstructured":"Brandt T, Sack LM, Arjona D et al (2020) Adapting ACMG\/AMP sequence variant classification guidelines for single-gene copy number variants. Genet Med 22:336\u2013344. https:\/\/doi.org\/10.1038\/s41436-019-0655-2","journal-title":"Genet Med"},{"key":"6499_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.jmoldx.2018.06.003","volume":"20","author":"JA Vendrell","year":"2018","unstructured":"Vendrell JA, Vilquin P, Larrieux M et al (2018) Benchmarking of amplicon-based next-generation sequencing panels combined with bioinformatics solutions for germline BRCA1 and BRCA2 alteration detection. J Mol Diagnostics 20:754\u2013764. https:\/\/doi.org\/10.1016\/j.jmoldx.2018.06.003","journal-title":"J Mol Diagnostics"},{"key":"6499_CR14","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/cncr.24200","volume":"115","author":"MJ Hall","year":"2009","unstructured":"Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115:2222\u20132233. https:\/\/doi.org\/10.1002\/cncr.24200","journal-title":"Cancer"},{"key":"6499_CR15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/humu.20723","volume":"29","author":"S Engert","year":"2008","unstructured":"Engert S, Wappenschmidt B, Betz B et al (2008) MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat 29:948\u2013958. https:\/\/doi.org\/10.1002\/humu.20723","journal-title":"Hum Mutat"},{"key":"6499_CR16","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1093\/hmg\/ddh301","volume":"13","author":"A Pavlicek","year":"2004","unstructured":"Pavlicek A, Noskov VN, Kouprina N et al (2004) Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition. Hum Mol Genet 13:2737\u20132751. https:\/\/doi.org\/10.1093\/hmg\/ddh301","journal-title":"Hum Mol Genet"},{"key":"6499_CR17","doi-asserted-by":"publisher","first-page":"17334","DOI":"10.18632\/oncotarget.24671","volume":"9","author":"SM Caputo","year":"2018","unstructured":"Caputo SM, L\u00e9one M, Damiola F et al (2018) Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and\/or ovarian cancer. Oncotarget 9:17334\u201317348. https:\/\/doi.org\/10.18632\/oncotarget.24671","journal-title":"Oncotarget"},{"key":"6499_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21134650","volume":"21","author":"A Bozsik","year":"2020","unstructured":"Bozsik A, P\u00f3cza T, Papp J et al (2020) Complex characterization of germline large genomic rearrangements of the BRCA1 and BRCA2 genes in high-risk breast cancer patients\u2014novel variants from a large national center. Int J Mol Sci 21:1\u201317. https:\/\/doi.org\/10.3390\/ijms21134650","journal-title":"Int J Mol Sci"},{"key":"6499_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/cge.12824","volume":"91","author":"P Apostolou","year":"2017","unstructured":"Apostolou P, Pertesi M, Aleporou-Marinou V et al (2017) Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation. Clin Genet 91:482\u2013487. https:\/\/doi.org\/10.1111\/cge.12824","journal-title":"Clin Genet"},{"key":"6499_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-121","author":"D Muller","year":"2011","unstructured":"Muller D, Rouleau E, Schultz I et al (2011) An entire exon 3 germline rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition. BMC Med Genet. https:\/\/doi.org\/10.1186\/1471-2350-12-121","journal-title":"BMC Med Genet"},{"key":"6499_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2147\/CLEP.S206949","volume":"11","author":"N Armstrong","year":"2019","unstructured":"Armstrong N, Ryder S, Forbes C et al (2019) A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol 11:543\u2013561","journal-title":"Clin Epidemiol"},{"key":"6499_CR22","unstructured":"Petrucelli N, Daly MB, Pal T (2016) BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. GeneReviews\u00ae. University of Washington, Seattle. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1247\/"},{"key":"6499_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/humu.22938","volume":"37","author":"MJ Smith","year":"2016","unstructured":"Smith MJ, Urquhart JE, Harkness EF et al (2016) The contribution of whole gene deletions and large rearrangements to the mutation spectrum in inherited tumor predisposing syndromes. Hum Mutat 37:250\u2013256. https:\/\/doi.org\/10.1002\/humu.22938","journal-title":"Hum Mutat"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06499-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06499-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06499-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T13:10:02Z","timestamp":1627477802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06499-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["6499"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06499-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"We confirm that we have read the journal\u2019s position on issues involved in the ethical publication, and we affirm that this report is consistent with those guidelines. The Ethics Committee of the University of Health Sciences, D\u0131\u015fkap\u0131 Y\u0131ld\u0131r\u0131m Beyaz\u0131t Training and Research Hospital approved the study (08.03.2021-106\/27).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patients or their parents (mentioned within \u201cPatients\u201d).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for the participation was taken from the patients or their parents involved in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent for the publication was taken from the patients or their parents involved in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}